Shang-mian Yie1, Robert N Taylor, Clifford Librach. 1. Department of Obstetrics and Gynecology, Sunnybrook and Women's College Health Sciences Centre (SWCHSC), Toronto, Ontario, Canada.
Abstract
OBJECTIVE: The aim of this study was to determine whether circulating HLA-G levels, early in pregnancy, predict the subsequent development of preeclampsia (PE). STUDY DESIGN: Plasma samples, collected longitudinally during the first, second, and third trimesters, from 12 PE patients and 12 matched control patients were tested for HLA-G protein using a validated sandwich ELISA. RESULTS: First and second trimester HLA-G levels in PE were significantly lower than in control patients (first trimester, 1.25 microg/mL vs 1.95 microg/mL, P=.029; second trimester, 1.11 microg/mL vs 1.90 microg/mL, P=.024). CONCLUSION: Our results indicate that HLA-G levels in plasma from women who subsequently develop PE are lower than control patients, as early as the first trimester. This suggests that determination of circulating HLA-G protein concentration may be useful as an early predictor for the development of PE.
OBJECTIVE: The aim of this study was to determine whether circulating HLA-G levels, early in pregnancy, predict the subsequent development of preeclampsia (PE). STUDY DESIGN: Plasma samples, collected longitudinally during the first, second, and third trimesters, from 12 PE patients and 12 matched control patients were tested for HLA-G protein using a validated sandwich ELISA. RESULTS: First and second trimester HLA-G levels in PE were significantly lower than in control patients (first trimester, 1.25 microg/mL vs 1.95 microg/mL, P=.029; second trimester, 1.11 microg/mL vs 1.90 microg/mL, P=.024). CONCLUSION: Our results indicate that HLA-G levels in plasma from women who subsequently develop PE are lower than control patients, as early as the first trimester. This suggests that determination of circulating HLA-G protein concentration may be useful as an early predictor for the development of PE.
Authors: Roberta Rizzo; Martine Vercammen; Hilde van de Velde; Peter A Horn; Vera Rebmann Journal: Cell Mol Life Sci Date: 2010-11-16 Impact factor: 9.261
Authors: A F Orozco; C J Jorgez; W D Ramos-Perez; E J Popek; X Yu; C A Kozinetz; F Z Bischoff; D E Lewis Journal: Placenta Date: 2009-08-18 Impact factor: 3.481
Authors: Sumati Rajagopalan; Yenan T Bryceson; Shanmuga P Kuppusamy; Daniel E Geraghty; Arnold van der Meer; Irma Joosten; Eric O Long Journal: PLoS Biol Date: 2006-01 Impact factor: 8.029